More importantly, our results of subchronic systemic administration of 7,8-DHF highlight the BDNF-TrkB pathway as the potential therapeutic targets for the treatment of cognitive deficits in stress-related psychiatric disorders. This evidence concerns the gene BDNF and psychiatric disorder.